Examination of IgM Rheumatoid Factor (IgM-RF) and Anti-cyclic Citrullinated Peptide Antibody (Anti-CCP Ab) in Japanese Patients with Palindromic Rheumatism

スポンサーリンク

概要

• 論文の詳細を見る

• We have studied the serology of 6 patients with palindromic rheumatism. None of the patients fulfilled the classification criteria for rheumatoid arthritis at the entry; however, 4 out of the 6 patients were seropositive for IgM rheumatoid factor (IgM-RF) at entry. Sequential serological study was performed in 4 patients; IgM-RF changed from seronegative to seropositive in one patient, and the titer increased in another patient. Anti-cyclic citrullinated peptide antibody (anti-CCP Ab) at the entry was detected in only one of the 6 patients; that patient later developed RA. Although follow-up is necessary, the present study may suggest the importance of serological examination, especially anti-CCP Ab, in patients with palindromic rheumatism.

• 日本内科学会の論文

著者

• Ida Hiroaki

  First Department Of Internal Medicine Graduate School Of Biochemical Sciences Nagasaki University

• Izumi Yasumori

  First Department Of Internal Medicine Nagasaki University Hospital Of Medicine And Dentistry Graduat

• Tanaka Fumiko

  First Department Of Internal Medicine Nagasaki University School Of Medicine

• Arima Kazuhiko

  First Department Of Internal Medicine Nagasaki University Hospital Of Medicine And Dentistry Graduat

• Kawakami Atsushi

  First Department Of Internal Medicine Nagasaki University Hospital Of Medicine And Dentistry Graduat

• Aratake Kouichiro

  First Department Of Internal Medicine Graduate School Of Biochemical Sciences Nagasaki University

• Huang Mingguo

  First Department Of Internal Medicine Nagasaki University Hospital Of Medicine And Dentistry Graduat

• Iwanaga Nozomi

  First Department Of Internal Medicine Graduate School Of Biochemical Sciences Nagasaki University

• Fujikawa Keita

  First Department Of Internal Medicine Institute Of Tropical Medicine Nagasaki University

• Eguchi Katsumi

  First Department Of Internal Medicine Graduate School Of Biochemical Sciences Nagasaki University

• Kamachi Makoto

  First Department Of Internal Medicine Nagasaki University Hospital Of Medicine And Dentistry Graduat

• Nakamura Hideki

  First Department Of Internal Medicine Graduate School Of Biomedical Sciences Nagasaki University

• Aramaki Toshiyuki

  First Department Of Internal Medicine Nagasaki University Hospital Of Medicine And Dentistry Graduate School Of Biomedical Sciences Nagasaki University

• Origuchi Tomoki

  Nagasaki University of Health Science, Nagasaki University

• Tamai Mami

  First Department of Internal Medicine Atomic Bomb Disease Institute, Nagasaki University School of Medicine

• Fujikawa Keita

  First Department of Internal Medicine, Graduate School of Biomedical Sciences

• Aramaki Toshiyuki

  First Department of Internal Medicine, Graduate School of Biomedical Sciences

• Iwanaga Nozomi

  First Department of Internal Medicine, Graduate School of Biomedical Sciences

• Huang Mingguo

  First Department of Internal Medicine, Graduate School of Biomedical Sciences

• Tamai Mami

  First Department of Internal Medicine, Graduate School of Biomedical Sciences

• Izumi Yasumori

  First Department of Internal Medicine, Graduate School of Biomedical Sciences

• Kamachi Makoto

  First Department of Internal Medicine, Graduate School of Biomedical Sciences

• Ida Hiroaki

  First Department of Internal Medicine, Graduate School of Biomedical Sciences

関連論文

• Enhanced effect of high-dose leukocytapheresis using a large filter in rheumatoid arthritis
• Sarcoidosis Accompanied by Systemic Lupus Erythematosus and Autoimmune Hepatitis
• Adult Still's disease associated with cytomegalovirus infection
• Prediction of DAS28-ESR remission at 6 months by baseline variables in patients with rheumatoid arthritis treated with etanercept in Japanese population
• Membraneous Glomerulonephritis and Non-Hodgkin's Lymphoma in a Patient with Primary Sjﾃｶgren's Syndrome
• Autoimmune hepatitis in a patient with systemic lupus erythematosus : a case report
• A case of Sjogren's syndrome presenting as hypokalemic myopathy due to distal renal tubular acidosis
• Catastrophic transverse myelitis in a patient with systemic lupus erythematosus
• Association of subacute cutaneous lupus erythematosus in a rheumatoid arthritis patient with Sjogren's syndrome
• A significantly impaired natural killer cell activity due to a low activity on a per-cell basis in rheumatoid arthritis
• Twenty-four-week follow-up examination of a leukocytapheresis therapy in rheumatoid arthritis
• Characterization of anticytoplasmic antibodies in patients with systemic autoimmune diseases
• A case of amyloidosis secondary to rheumatoid arthritis complicated with Graves' ophthalmopathy
• Atypical mycobacteriosis in two patients with rheumatoid arthritis
• Successful Combined Therapy of Cyclophosphamide and Cyclosporine for Acute Exacerbated Interstitial Pneumonia Associated with Dermatomyositis
• Nonalcoholic Steatohepatitis with Improved Hepatic Fibrosis after Weight Reduction
• Clinical Features of Fulminant Hepatitis in Nagasaki Prefecture, Japan
• Spontaneous loss of hepatitis B surface antigen in chronic carriers, based on a long-term follow-up study in Goto Islands, Japan
• Deep vein thrombosis and pulmonary thromboembolism in a patient with eosinophilia and obesity
• Thyrotropin Secreting Pituitary Adenoma Effectively Treated with Octreotide
• Lens culinaris agglutinin-reactive α-fetoprotein and protein induced by vitamin K absence II are potential indicators of a poor prognosis : a histopathological study of surgically resected hepatocellular carcinoma
• Genome-wide linkage analysis of type 2 diabetes mellitus reconfirms the susceptibility locus on 11p13-p12 in Japanese
• Successful plasmapheresis in alveolar hemorrhage associated with systemic lupus erythematosus
• Tyrphostin AG 1478 Accelerates Hydrogen Peroxide-Induced Apoptosis in A431 Cells
• A case of periodic-fever-syndrome-like disorder with lipodystrophy, myositis, and autoimmune abnormalities
• Transient Appearance of Lactate Dehydrogenase (LDH)-linked Immunoglobulin and Thyroid Dysfunction at the Postpartum Period
• Hereditary Periodic Fever Syndromes in Japan
• Update on the Japanese guidelines for the use of infliximab and etanercept in rheumatoid arthritis
• Guidelines for the proper use of etanercept in Japan
• Increased mRNA Expression of Th1-Cytokine Signaling Molecules in Patients with HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis
• Multicentric reticulohistiocytosis associated with ovarian cancer
• Role of HTLV-I infection in the pathogenesis of Sjogren's syndrome and rheumatoid arthritis
• Anti-Thyroid Drug-Induced ANCA-Associated Vasculitis: A Case Report and Review of the Literature
• Cutaneous vasculitis induced by TNF inhibitors : a report of three cases
• Switching to the anti-interleukin-6 receptor antibody tocilizumab in rheumatoid arthritis patients refractory to antitumor necrosis factor biologics
• Prediction of DAS28-CRP remission in patients with rheumatoid arthritis treated with tacrolimus at 6 months by baseline variables
• Vasculo-Behcet's syndrome with widespread arterial involvement
• Successful treatment of chronic lupus myocarditis with prednisolone and mizoribine
• Contribution of an adenine to guanine single nucleotide polymorphism of the matrix metalloproteinase-13 (MMP-13) -77 promoter region to the production of anticyclic citrullinated peptide antibodies in patients with HLA-DRB1^*shared epitope-negative rheuma
• Reduction in serum levels of substance P in patients with rheumatoid arthritis by etanercept, a tumor necrosis factor inhibitor
• Putative IgG4-related pituitary disease with hypopituitarism and/or diabetes insipidus accompanied with elevated serum levels of IgG4
• Emergence of anti-islet autoantibodies in Japanese patients with type 1 diabetes
• First Japanese Patient Treated with Parathyroid Hormone Peptide Immunization for Refractory Hypercalcemia Caused by Metastatic Parathyroid Carcinoma
• In rheumatoid arthritis patients treated with tocilizumab, the rate of clinical disease activity index (CDAI) remission at 24 weeks is superior in those with higher titers of IgM-rheumatoid factor at baseline
• Disease activity score 28 may overestimate the remission induction of rheumatoid arthritis patients treated with tocilizumab : comparison with the remission by the clinical disease activity index
• Successful Treatment of a Patient with Primary Sjögren's Syndrome Complicated with Pericarditis during Pregnancy
• Blockade of IL-2 Receptor Suppresses HTLV-I and IFN-ﾎｳ Expression in Patients with HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis
• Delayed treatment with tumor necrosis factor inhibitors in incomplete responders to synthetic disease-modifying anti-rheumatic drugs shows and excellent effect in patients with very early rheumatoid arthritis with poor prognosis factors
• A patient with systemic lupus erythematosus who developed massive small intestinal hemorrhaging during treatment for chronic lupus peritonitis
• Treatment discontinuation in patients with very early rheumatoid arthritis in sustained simplified disease activity index remission after synthetic disease-modifying anti-rheumatic drug administration
• A case of Sjogren's syndrome presenting as trigeminal nerve palsy
• Thyroid papillary carcinoma with solid sclerosing change in IgG4-related sclerosing disease
• Type B Insulin Resistance Complicated with Systemic Lupus Erythematosus
• Non-specific Activities against Ruthenium Crosslinker as a New Cause of Assay Interference in an Electrochemilluminescent Immunoassay
• Examination of IgM Rheumatoid Factor (IgM-RF) and Anti-cyclic Citrullinated Peptide Antibody (Anti-CCP Ab) in Japanese Patients with Palindromic Rheumatism
• Infliximab is Effective for Takayasu Arteritis Refractory to Glucocorticoid and Methotrexate

もっと見る 閉じる

スポンサーリンク